CSBR:NASDAQ
Champions Oncology Inc
USD 4,64
arrow_downward
-0,85%(-0,040) 1D
17 Nov., 10:50:28 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
USD 4,70
High
USD 4,70
Low
USD 4,60
Mkt. cap
64,58 m
Avg. vol.
7,80 k
Volume
3,78 k
52-wk high
USD 8,31
52-wk low
USD 4,52
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
Open
USD 4,70
High
USD 4,70
Low
USD 4,60
Mkt. cap
64,58 m
Avg. vol.
7,80 k
Volume
3,78 k
52-wk high
USD 8,31
52-wk low
USD 4,52
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
News stories
From web sources and news partners
ChartMill
·
59 minute gelede
Today's S&P 500 Top Movers: Reddit Leads Gainers, Salesforce Leads Decliners
MarketWatch
·
59 minute gelede
Why Salesforce’s stock is leading S&P 500 decliners amid tech jitters
24/7 Wall St.
·
33 minute gelede
Bill Ackman Cut His Microsoft Stake. Your S&P 500 Fund Can’t.
BigGo Finance
·
1 uur gelede
Netflix Shares Trade Below S&P 500 Multiple After 35% Slide as Analysts See Upside
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, Verenigde State van Amerika
SectorHealth Care
Industry-
Websitechampionsoncology.com